The ITGA6 gene provides instructions for part of a protein that helps cells attach firmly to the thin support layer beneath them, especially in the skin and other body linings. This gene plays an important role in keeping tissues stable as they grow and cope with everyday friction. When both copies carry harmful variants, babies can have very fragile skin with blistering and may also be born with a blocked stomach outlet. Some may also have problems affecting the nails, breathing, or urinary tract.
What is a gene?
A gene is a section of DNA that holds instructions your cells can use to make molecules or regulate processes in the body. Some genes provide the information needed to make proteins, which do much of the work inside cells. Other genes mainly control when certain processes happen, where they happen, and how active they are. Taken together, genes affect how the body grows and works, and they can influence how you respond to food, stress, or medications. To look into this topic more deeply, you can find more in the LearnHub.
Overview
ITGA6Gene function
What if the gene works
The ITGA6 gene helps cells attach to the thin support layer beneath them. This supports stable skin, lining tissues, and early development.
Risk
What if the gene does not work
Variants in the ITGA6 gene often affect skin and digestive tract lining, leading to junctional epidermolysis bullosa with pyloric atresia. Milder to more severe variants can change how early problems appear and how much skin blistering and stomach outlet blockage occur.
Treatment
What does that mean for your treatment
No treatment or drug choice approach specific to the ITGA6 gene is currently established in clinical guidelines. Care is guided by symptoms and complications rather than the exact ITGA6 variant. The ITGA6 gene is also being studied as a cancer biomarker and possible drug target, but this has not led to routine gene directed treatment.
Conditions associated with ITGA6
Gene function
What if the gene works
Your skin and many body linings need a secure hold on the layer beneath them to handle everyday rubbing and stretching. The ITGA6 gene helps provide that hold by letting cells grip laminin, a key protein in their support layer. Understanding the function of the ITGA6 gene helps explain how tissues stay attached, organized, and steady.
The ITGA6 gene helps cells attach to laminin, an important protein in the thin support layer under many tissues. This attachment gives surface cells a stable point of contact with the structure below.
In skin and other body linings, its protein helps form anchoring structures that fasten cells to the basement membrane (the supportive sheet under cells). This support helps tissues stay steady during normal friction, stretching, and movement.
By connecting cells to their surroundings, the ITGA6 gene also helps pass signals that support cell shape, movement, and survival. These signals help tissues grow, renew, and stay organized in everyday life.
What is a variant?
A genetic variant is a small change in the DNA sequence within a gene. These changes are common and help shape normal human diversity, including differences in appearance, metabolism, and how the body responds to environmental influences. Many variants do not have any noticeable effect and are simply part of natural genetic variation. In some cases, though, a variant can change how a gene functions more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the ITGA6 gene can change the shape, stability, or amount of the alpha-6 integrin protein, so it may not join properly with partner proteins or hold cells firmly in place. This explains how variants in the ITGA6 gene affect protein function at the cell surface. Milder variants may leave some activity, while more severe loss-of-function variants can leave little or no working protein, often leading to earlier and more pronounced epidermolysis bullosa with pyloric atresia.
How variants are linked to conditions
Pathogenic variants in the ITGA6 gene are best known for causing epidermolysis bullosa with pyloric atresia, a rare inherited condition that can cause fragile, blistering skin and a blockage at the stomach outlet. In some families, pyloric atresia linked to the ITGA6 gene appears with little or no skin involvement. When pathogenic variants are found in both copies of the ITGA6 gene, they can confirm this diagnosis.
A variant is not necessarily a diagnosis
Genetic variants are common across the general population and are a normal feature of human biology. Most do not directly affect health and simply reflect natural variation among people. For many genes, carrying a variant associated with a condition indicates a possible link rather than a certain diagnosis, especially when several genes and environmental factors are involved. In some situations, however, a single well-characterized variant in a specific gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For ITGA6-related conditions, risk is driven mainly by the genetic change itself rather than by lifestyle or everyday exposures. Risk is higher when a changed ITGA6 gene runs in the family, especially if both parents carry one; there is not enough evidence to say that diet, exercise, or other routine habits lower this risk.
Inheritance of ITGA6 variants
For families wondering how variants of the ITGA6 gene are inherited, the well-established pattern for ITGA6-related conditions is autosomal recessive. This means a child usually inherits one altered copy from each parent, and parents who carry one copy are often unaffected themselves. When both parents carry an ITGA6 variant, each pregnancy has a 25% chance of the child inheriting both altered copies, a 50% chance of being a carrier, and a 25% chance of inheriting neither altered copy. Because the ITGA6 gene is on chromosome 2, this pattern is the same for boys and girls.
What does my ITGA6 result mean for my family?
For ITGA6, the main well-known family pattern is recessive. This usually means both parents are healthy carriers, and brothers or sisters may also be affected or may be carriers. Other relatives on both sides of the family can sometimes carry the same gene change, especially if there is a family history of a related skin and digestive tract condition.
Genetic information
Genetic testing
How you find out about variants
To look for changes in the ITGA6 gene, doctors use genetic testing for ITGA6 variants, usually on a blood or saliva sample. A lab reads the gene’s DNA code and may also check for missing or extra pieces. Results can show a disease-causing variant, a variant of uncertain significance, or no relevant variant.
When should I consider getting a genetic test?
Genetic testing for the ITGA6 gene may be considered if a baby is born with severe skin blistering, fragile skin, and a blockage at the outlet of the stomach or intestine, or if this condition runs in the family. It can help confirm the cause and clarify the chance of it happening again in another pregnancy.
A genetic result is only one part of your health story
Genetic findings can be informative, but how much they reveal varies with the condition and the specific variant involved. Over time, the way the body functions is shaped by many factors, including lifestyle, environment, age, and medical history. For some conditions, especially those affected by many genes, genetic information provides context rather than certainty and is best considered alongside other parts of care. In other situations, a genetic result may offer a clear answer. In areas like medication response, genetic results can help put personal experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Small differences in DNA can change how the body absorbs, breaks down, or responds to a drug, so the same treatment may work well for one person but less well for another. This is common and can influence how much benefit someone gets from a medicine or how sensitive they are to side effects.
What is Pharmacogenetics?
Pharmacogenetics examines how differences in genes affect the way people respond to medications. It studies the relationship between genes and drugs to help explain why the same treatment can work differently from one person to another. For many medicines, genes influence both how the body processes a drug and how strong its effects are. This information can support more informed, individualized treatment decisions. More on this topic is available in the LearnHub.
Drugs influenced by the ITGA6 gene
When should I seek medical advice?
At this time, this gene does not have a broadly confirmed role in guiding how medicines are chosen or adjusted. Questions about side effects, new symptoms, or whether a treatment is working are best discussed with your doctor or pharmacist.
History
ITGA6 entered the scientific literature in the late 1980s, when researchers studying cell surface proteins identified alpha 6 integrin, also called CD49f. Early work placed it within the newly emerging integrin family, a group of genes that helped reshape understanding of how cells attach to their surroundings. From these first observations, research expanded steadily. In the 1990s, ITGA6 became important in studies of skin adhesion and inherited blistering conditions, helping connect basic cell biology with clinical genetics. It also gained attention as a marker used to identify certain stem and progenitor cell populations in laboratory research. Over time, scientists’ understanding of the ITGA6 gene’s role in human disease and tissue biology became more precise.